Enanta Pharmaceuticals (ENTA) Tax Provisions (2014 - 2026)
Enanta Pharmaceuticals posted quarterly Tax Provisions of $7000.0 for Q1 2026, up 100.54% year-on-year from $3490.6 in Q1 2025, and down 70.83% on a QoQ basis from $24000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 13 years of Tax Provisions data on file, last reported at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 100.54% year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (up 103.44% YoY), and the FY2025 full-year result was -$1.7 million, up 14.26% from the prior year.
- Tax Provisions for Q1 2026 stood at $7000.0, down from $24000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $4.2 million in Q2 2023 and bottomed at -$1.4 million in Q3 2023.
- The 5-year median for Tax Provisions is -$198500.0 (2022), against an average of -$73562.5.
- Peak annual rise in Tax Provisions reached 1044.3% in 2023, while the deepest fall reached 10171.43% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$34000.0 in 2022, then slumped by 1729.41% to -$622000.0 in 2023, then surged by 33.12% to -$416000.0 in 2024, then surged by 105.77% to $24000.0 in 2025, then sank by 70.83% to $7000.0 in 2026.
- The last three Tax Provisions figures came in at $7000.0 (Q1 2026), $24000.0 (Q4 2025), and $32000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | -416,000.00 |
| Sep 30, 2024 | -556,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Mar 31, 2024 | -363,000.00 |
| Dec 31, 2023 | -622,000.00 |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | -447,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | 48.51 Mn |
| Jun 30, 2021 | -9.38 Mn |
| Mar 31, 2021 | 7.11 Mn |
| Dec 31, 2020 | -3.29 Mn |
| Sep 30, 2020 | 10.71 Mn |
| Jun 30, 2020 | -7.14 Mn |
| Mar 31, 2020 | -3.92 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | -486,000.00 |
| Jun 30, 2019 | -866,000.00 |
| Mar 31, 2019 | -3.20 Mn |
| Dec 31, 2018 | 3.73 Mn |
| Sep 30, 2018 | 8.46 Mn |
| Jun 30, 2018 | 3.69 Mn |
| Mar 31, 2018 | 5.37 Mn |
| Dec 31, 2017 | 3.64 Mn |
| Sep 30, 2017 | -18.45 Mn |
| Jun 30, 2017 | 4.10 Mn |
| Mar 31, 2017 | 3.57 Mn |
| Dec 31, 2016 | 1.54 Mn |
| Sep 30, 2016 | 826,000.00 |
| Jun 30, 2016 | -434,000.00 |
| Mar 31, 2016 | -1.55 Mn |
| Dec 31, 2015 | -9.73 Mn |
| Sep 30, 2015 | 1.63 Mn |
| Jun 30, 2015 | 428,000.00 |
| Mar 31, 2015 | -20.02 Mn |
| Dec 31, 2014 | -28.50 Mn |
| Sep 30, 2014 | 48,000.00 |
| Jun 30, 2014 | 15.12 Mn |